Voices Podcast – Episode #1: Breast Cancer ‘SoulMates’

0

When Melissa Angiolillo was diagnosed with breast cancer in January 2015, she had all the support of her husband, family and friends. But what she really needed was someone who had gone through what she was about to experience, someone who knew what it was like to face a stage III breast cancer diagnosis.

Melissa and Noel at the 2015 WEEI/NESN Jimmy Fund Radio-Telethon.

Melissa and Noel at the 2015 WEEI/NESN Jimmy Fund Radio-Telethon.

Enter Noel Peters.

“From the very beginning, I was given the opportunity, because of [Noel], to just be real about my diagnosis and to not feel that pressure of putting on a happy face,” says Angiolillo. “I hope that one day I will be able to do for even one young woman what [Noel] has done for me.”

Peters was matched with Angiolillo as part of the SoulMates program offered to breast cancer patients through the Susan F. Smith Center for Women’s Cancers at Dana-Farber. The peer support program pairs survivor mentors with new patients who have similar diagnoses.

Both Angiolillo and Peters began to meet shortly after Angiolillo’s diagnosis and a connection formed immediately. Now, as both women are finished active treatment, the mentor-mentee relationship has blossomed into a friendship beyond breast cancer.

Hear their story by listening to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Android and RSS.

The Voices podcast series features stories from cancer patients who share their experiences coping with their life-changing diagnoses and treatment. Season 1 of Voices features breast cancer patients. Visit the Voices page for more episodes and Dana-Farber’s podcast page for more information on other cancer podcast series.

Editor’s note: Judie and Larry Schlager have made several generous gifts to help establish and grow the SoulMates program.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber clinicians have been involved in the development of several new agents approved recently for B-cell acu… https://t.co/Oo3SiY79EN
Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.